133 related articles for article (PubMed ID: 10812659)
1. [Screening for markers of infections transmitted by transfusions in the blood collected in France from 1996 to 1998].
Couroucé AM; Pillonel J; Saura C
Transfus Clin Biol; 2000 Apr; 7(2):153-70. PubMed ID: 10812659
[TBL] [Abstract][Full Text] [Related]
2. [Screening for markers of blood-borne diseases in donated units collected in France from 1993 to 1995].
Saura C; Pillonel J; Couroucé AM
Transfus Clin Biol; 1997 Jul; 4(4):403-15. PubMed ID: 9333419
[TBL] [Abstract][Full Text] [Related]
3. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
[TBL] [Abstract][Full Text] [Related]
5. [Controlled viral risks].
Barin F
Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
[TBL] [Abstract][Full Text] [Related]
6. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
[TBL] [Abstract][Full Text] [Related]
7. Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.
Cruz JR; Pérez-Rosales MD; Zicker F; Schmunis GA
J Clin Virol; 2005 Dec; 34 Suppl 2():S75-80. PubMed ID: 16461244
[TBL] [Abstract][Full Text] [Related]
8. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
9. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.
Yao F; Seed C; Farrugia A; Morgan D; Cordner S; Wood D; Zheng MH
Am J Transplant; 2007 Dec; 7(12):2723-6. PubMed ID: 17983391
[TBL] [Abstract][Full Text] [Related]
10. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
Whyte GS; Savoia HF
Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
[TBL] [Abstract][Full Text] [Related]
11. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H;
Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342
[TBL] [Abstract][Full Text] [Related]
12. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
13. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
[TBL] [Abstract][Full Text] [Related]
14. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
Soldan K; Barbara JA; Ramsay ME; Hall AJ
Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
[TBL] [Abstract][Full Text] [Related]
16. How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus?
Rabenau H; Schütz R; Berger A; Doerr HW; Weber B
Infusionsther Transfusionsmed; 1996 Jun; 23(3):124-30. PubMed ID: 8782708
[TBL] [Abstract][Full Text] [Related]
17. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
18. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients.
Covas DT; Boturão Neto E; Zago MA
Rev Inst Med Trop Sao Paulo; 1993; 35(3):271-3. PubMed ID: 8278757
[TBL] [Abstract][Full Text] [Related]
19. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
Ben Jemia R; Gouider E
Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
